Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Based Pharmacokinetic and Pharmacodynamic Dosage Model for Cytarabine, Daunorubicin and Etoposide for Acute Myeloid Leukemia

NCT00969891 is registered in ClinicalTrials.gov with Mikkel Krogh-Madsen as lead sponsor.

NCT NCT00969891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00969891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Based Pharmacokinetic and Pharmacodynamic Dosage Model for Cytarabine, Daunorubicin and Etoposide for Acute Myeloid Leukemia
Lead sponsor
Mikkel Krogh-Madsen
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
August 31, 2011
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia